Genetic Engineering and Biotechnology News (GEN) is the longest-running, most widely read, and largest circulated global biotechnology news publication. Published 21 times a year and recently redesigned to focus on Biobusiness, OMICS, Drug Discovery, Bioprocessing, and Translational Medicine, GEN reports on key news developments and technology trends in the bioindustry.

Immune Regulation News is one of Connexon’s 20 free, weekly science newsletters. It features the most current publications, reviews and press releases from high impact factor peer reviewed journals as well as respected academic and research institutions every week. Connexon’s expert editorial team hand-compiles research that focuses on the regulation—including the activation, suppression and modulation—of the immune system. They also feature the latest press releases discussing clinical trials related to immune regulation and immunotherapy, new research funding and award announcements, and relevant international job postings and conferences alerts.

Human Immunology News is one of Connexon’s 20 free, weekly science newsletters. It provides up-to-date coverage of the latest news in immunology research using human subjects or human cells. Connexon’s expert editors hand-pick recent research papers and review articles from relevant, high impact, peer reviewed journals. Their publications focus on human immune cell responses and interactions associated with autoimmunity, immunotherapy, reproductive and adaptive immunity as well as cancer vaccine research. In addition, the newsletter features press releases from top academic and industrial institutions discussing immunotherapy trials, award announcements and funding opportunities.

Immunology of Infectious Disease News is one of Connexon’s 20 free, weekly science newsletters. It features recent scientific articles and reviews from high impact peer-reviewed journals. It focuses on immune responses to infectious diseases such as hepatitis, tuberculosis, influenza, and malaria. Each issue also includes a section dedicated to HIV research. In addition to recent research papers and reviews, press releases discussing clinical research, vaccine trials, and funding opportunities are featured. Connexon’s editors also update readers on relevant international job postings and conference announcements to keep the immunology community engaged and up to date.

Genes (IF 3.242, ISSN 2073-4425) is an international, peer-reviewed, open access journal which provides an advanced forum for studies related to basic, translational and clinical aspects of genetics and genomics. It publishes reviews, research articles, communications and technical notes. Topics covered in Genes include but are not limited to: gene structure, gene expression, recombination and linkage, genetic mapping, monogenic and multifactorial hereditary disorders, medical genetics, gene therapy, personalized medicine, population genetics, phylogenetics, sequencing technologies and bioinformatics.

MabDesign is a French membership organization that aims to structure, mobilize and support the development of the French industrial sector in the field of immunotherapy.
MabDesign provides strategic leverage and development opportunities for its members.
These initiatives include: The creation of a unique nationwide directory of antibody stakeholders allowing the identification of expertise and potential partners. The access to innovative training solutions. The business development and marketing support. The organisation of events, thus promoting innovation and networking.

Oncology Central: Oncology is a fast-moving, multidisciplinary field at the forefront of medical research. At Oncology Central, the online resource powered by Future Science Group, we unite all aspects of oncology to support synergistic progression in the field through collaboration and learning.
Designed exclusively for medical professionals, and endorsed by an expanding board of expert Ambassadors from across the globe, we deliver high-quality and relevant content in an accessible and innovative way. Every day we aim to help you stay up to date with the latest developments in cancer research by providing the latest news, opinion, peer-reviewed journal articles, multimedia and exclusive content that can be digested quickly and easily.

Absave is the leading savings website for Antibodies and Immunological Products with over 1million products.  Search our extensive database of Antibodies, Kits, Proteins & Peptides, Reagents, etc. to find the best savings.

Biosave is the leading savings website for Life Scientists.  Search 1,000’s of products from leading suppliers to locate the best products at the most competitive prices.

Labsave is the leading savings website for Laboratory Equipment.  Discover an extensive range of products at the best prices and find the best savings for your lab.

Iptechex Pharmalicensing is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide.
Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique Partnering Search service and its global network of industry experts to enable companies to identify and engage with appropriate partners around the world.

Medgenera–A Biopreneurs News Network is a globally leading digital media platform for business, finance and innovations in biotech, pharma, chemistry and healthcare industries. Visit this platform for most updated coverage of research, entrepreneurship, and health and wellness news, jobs and events updates, expert’s insights/commentaries, progressive reviews on cutting-edge research and trending topics in bio-entrepreneurship and business, CEOs and bio-entrepreneurs interviews etc.

Medical News Today is the largest independent medical and health news site on the web – with 10,000,000 monthly unique users it is ranked number one for medical news on all major search engines. Medical News Today is used by pharmaceutical, biotech and health organizations, advertising agencies, PR companies and vertical ad networks to deliver targeted campaigns to HCPs, patients and caregivers. To find out how Medical News Today can help you to reach the right audience contact peter@medicalnewstoday.com

Pharmaceutical-Tech : “In the realm of Pharmacy, where innovation is rapid, Pharmaceutical-Tech stands adept at conceptualizing unique ideas relevant to the B2B space. Pharmaceutical-Tech is essentially a B2B online business, technology media platform and global magazine that have under its wraps the largest global database of Pharmacy buyers and suppliers.

Pharmaceutical-Tech.com covers in-depth trends that shape industry dynamics and metamorphose global economics. With services like search engine optimization, global magazine, social media marketing, product video showcase, e-mail marketing, e-newsletter sponsorship, banner advertising, event marketing and micro-website within our platform, www.pharmaceutical-tech.com has created a recognition that spans over a global audience, thereby revolutionizing how businesses transact.”

PharmaVision offers a consultancy service providing high quality, due diligence research and independent, tailor made life science reports to pharmaceutical companies, competitive intelligence specialists, investment institutions and healthcare communication agencies. The research reports combine in-depth interviews with key opinion leaders, scientific analysis with market models to forecast the potential growth of key developmental products and technologies, identify marker drivers/resistors and identify unique selling features to guide product development and market positioning, and to assess the challenges and opportunities which surround this specialist sector.

PharmaVOICE magazine provides commentary about the challenges and trends impacting the life-sciences industry, covering a range of issues from molecule through market. PharmaVOICE’s more than 41,000 BPA-qualified subscribers are also kept abreast of the latest trends through additional media resources, including WebSeminars, Podcasts, Videocasts, and White Papers.